Early M‐Protein Dynamics Predicts Progression‐Free Survival in Patients With Relapsed/Refractory Multiple Myeloma

This study aimed to predict long‐term progression‐free survival (PFS) using early M‐protein dynamic measurements in patients with relapsed/refractory multiple myeloma (MM). The PFS was modeled based on dynamic M‐protein data from two phase III studies, POLLUX and CASTOR, which included 569 and 498 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xiaoyu, Xu, Xu Steven, Weisel, Katja C., Mateos, Maria‐Victoria, Sonneveld, Pieter, Dimopoulos, Meletios A., Usmani, Saad Zafar, Bahlis, Nizar J., Puchalski, Thomas, Ukropec, Jon, Bellew, Kevin, Ming, Qi, Sun, Steven, Zhou, Honghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719372/
https://www.ncbi.nlm.nih.gov/pubmed/32583948
http://dx.doi.org/10.1111/cts.12836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719372/
https://www.ncbi.nlm.nih.gov/pubmed/32583948
http://dx.doi.org/10.1111/cts.12836

Ejemplares similares